Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis

Completed

• Conditions: Arthropathy of Hip; Perioperative/Postoperative Complications
• Interventions: Behavioral: home support, hiving alone; Behavioral: home support, living with others

• Registration Number: NCT06462885
• Lead Sponsor: University of Virginia

Brief Summary

The goal of this observational study is to assess the effect of living alone on total hip arthroplasty thirty-day outcomes. The main questions it aims to answer are:

Is living alone associated with discharge disposition (home versus non-home)? Is living alone associated with greater incidences of secondary adverse events?

Participants will be sampled from the 2021 American College of Surgeons National Surgical Quality Improvement Program

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-01
• Primary Completion: 2022-01-30
• Study Completion: 2022-01-30
• Status Verified: 2024-06
• Study First Submitted: 2024-06-11
• Study First Submitted QC: 2024-06-11
• Last Update Submitted: 2024-06-16
• Study First Posted: 2024-06-17
• Last Update Posted: 2024-06-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5677

Inclusion Criteria

• Elective, non-emergent cases
• Living alone
• Living with others

Exclusion Criteria

• Fracture in surgical diagnosis
• Hospital admission >1 day preoperatively
• End-stage renal disease (preoperative)
• Metastatic disease (preoperative)
• Sepsis (preoperative)
• Bleeding diathesis (preoperative)
• American Society of Anesthesiologists Physical Status Classification 5

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Living alone	home support, hiving alone	1,624 patients undergoing elective total hip arthroplasty who were living alone at the time of admission.
Living with others	home support, living with others	1,624 patients undergoing elective total hip arthroplasty who were living with others at the time of admission.

Primary Outcome Measures

Name	Time	Method
Discharge disposition	Thirty days	Home versus non-home

Secondary Outcome Measures

Name	Time	Method
Hospital length of stay	Thirty days
Wound complications	Thirty days	Superficial surgical site infection (SSI), deep incisional SSI, organ space SSI, and wound dehiscence
Requiring home services	Thirty days
Postoperative delirium	Thirty days
Unplanned resource utilization	Thirty days	Unplanned readmission and return to the operating room
Functional status at discharge	Thirty days	Dependent versus independent
Bleeding events	Thirty days	Requiring transfusion
Mortality	Thirty days
Systemic complications	Thirty days	Cardiac arrest, myocardial infarction, stroke, reintubation, pneumonia, deep venous thrombosis, pulmonary embolism, bleeding, sepsis, septic shock, and acute kidney injury

Trial Locations

Locations (1)

University of Virginia; 🇺🇸 Charlottesville, Virginia, United States